CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hospira	TPN ELECTROLYTES IN PLASTIC CONTAINER	calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride	INJECTABLE;INJECTION	018895	NDA	Hospira, Inc.	0409-5779-01	25 VIAL, SINGLE-DOSE in 1 CARTON (0409-5779-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-5779-11)	2005-02-28
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: February 19, 2026

This report analyzes the supply landscape for key pharmaceutical-grade electrolyte salts: calcium chloride, magnesium chloride, potassium chloride, sodium acetate, and sodium chloride. The analysis focuses on identifying major manufacturers, production capacities, geographical distribution, regulatory compliance, and current market trends impacting their availability and pricing for pharmaceutical applications.

What are the primary pharmaceutical applications of these electrolyte salts?

These electrolyte salts are fundamental components in a wide array of pharmaceutical products due to their essential roles in maintaining physiological balance and as excipients.

Calcium Chloride (CaCl2): Utilized in intravenous solutions for treating hypocalcemia, as a source of calcium in parenteral nutrition, and as a stabilizing agent in certain formulations. It also acts as a firming agent in some drug products.
Magnesium Chloride (MgCl2): Administered intravenously to correct magnesium deficiencies, a common complication in critical care and patients with gastrointestinal disorders. It is also found in parenteral nutrition solutions and oral rehydration therapies.
Potassium Chloride (KCl): The primary salt used to treat hypokalemia, a potentially life-threatening condition characterized by low blood potassium levels. It is a staple in intravenous fluid therapy and oral potassium supplements.
Sodium Acetate (CH3COONa): Used to treat metabolic acidosis by providing a source of bicarbonate precursor. It is also a component in hemodialysis solutions and some intravenous fluids for electrolyte replenishment.
Sodium Chloride (NaCl): The most ubiquitous electrolyte salt, forming the basis of normal saline (0.9% NaCl) intravenous solutions for hydration, blood pressure support, and drug vehicle. It is also a critical component in oral rehydration salts and various topical and oral formulations.

Who are the leading global manufacturers of these pharmaceutical-grade salts?

The production of pharmaceutical-grade salts requires stringent adherence to Good Manufacturing Practices (GMP) and pharmacopoeial standards (e.g., USP, EP, JP). Key manufacturers operate large-scale facilities, often integrated with raw material sourcing.

Calcium Chloride Manufacturers:

Cargill, Inc. (USA): A significant producer with a global presence, offering various grades of calcium chloride. Their pharmaceutical-grade material is produced under strict quality controls.
OCI Wyoming, LP (USA): A major North American supplier of calcium chloride, with dedicated facilities for producing food and pharmaceutical grades.
Solvay S.A. (Belgium): A global chemical company with a substantial calcium chloride division, supplying to pharmaceutical markets worldwide.
Weifang Ocean Chemical Industry Group Co., Ltd. (China): A prominent Chinese producer with significant export capacity for pharmaceutical-grade calcium chloride.
DL Chemical Co., Ltd. (South Korea): Offers pharmaceutical-grade calcium chloride as part of its broader chemical portfolio.

Magnesium Chloride Manufacturers:

Cargill, Inc. (USA): Supplies pharmaceutical-grade magnesium chloride, often sourced from natural brines.
U.S. Magnesium, LLC (USA): A primary producer of magnesium metal and magnesium compounds, including high-purity magnesium chloride for pharmaceutical use.
Albemarle Corporation (USA): While known for other specialties, Albemarle has capabilities in producing magnesium compounds, including pharmaceutical grades.
Tata Chemicals Limited (India): A diversified chemical company with production of magnesium chloride, serving various industrial and pharmaceutical needs.
Lanxess AG (Germany): Offers magnesium chloride as part of its specialty chemicals portfolio, meeting pharmaceutical quality standards.

Potassium Chloride Manufacturers:

Uralkali PJSC (Russia): One of the world's largest producers of potash fertilizers, with significant capacity for high-purity potassium chloride used in pharmaceutical applications.
The Mosaic Company (USA): A major North American producer of potash, supplying pharmaceutical-grade potassium chloride.
Nutrien Ltd. (Canada): A leading global producer of crop inputs, with substantial potash operations capable of producing USP/EP grade potassium chloride.
JSC Belaruskali (Belarus): Another major global potash producer with extensive capacity for pharmaceutical-grade potassium chloride.
SQM (Sociedad Química y Minera de Chile) (Chile): A significant producer of specialty plant nutrients and industrial chemicals, including pharmaceutical-grade potassium chloride.

Sodium Acetate Manufacturers:

Eastman Chemical Company (USA): A large producer of acetic acid derivatives, including sodium acetate, manufactured to pharmaceutical specifications.
J.T. Baker (Avantor) (USA): Known for high-purity chemicals for laboratory and pharmaceutical use, offering pharmaceutical-grade sodium acetate.
TCI America (Tokyo Chemical Industry) (USA/Japan): A global supplier of specialty organic chemicals, including pharmaceutical-grade sodium acetate.
Shanxi Huachang Pharmaceutical Co., Ltd. (China): A significant Chinese producer of pharmaceutical intermediates and excipients, including sodium acetate.
BASF SE (Germany): Offers a range of chemical products, including sodium acetate, meeting stringent pharmaceutical quality standards.

Sodium Chloride Manufacturers:

Cargill, Inc. (USA): A dominant player in the salt market, producing pharmaceutical-grade sodium chloride (e.g., USP Purified Salt) from various sources.
AkzoNobel N.V. (Netherlands): Produces high-purity vacuum salt suitable for pharmaceutical applications.
Compagnie de Salins du Midi et des Salines d'Assaouira (Salins Group) (France): A major European salt producer with pharmaceutical-grade offerings.
K+S Aktiengesellschaft (Germany): A significant European producer of potash and salt, including pharmaceutical-grade sodium chloride.
China Salt Industry Corporation (China): The largest salt producer in China, with capabilities to produce pharmaceutical-grade sodium chloride for domestic and export markets.

What is the geographical distribution of production?

Production of these electrolyte salts is geographically diverse, driven by access to raw materials and established chemical manufacturing hubs.

North America (USA, Canada): Strong presence in calcium chloride (OCI, Cargill), magnesium chloride (Cargill, U.S. Magnesium), potassium chloride (Mosaic), sodium acetate (Eastman), and sodium chloride (Cargill). These regions benefit from advanced regulatory frameworks and sophisticated supply chains.
Europe (Germany, Belgium, Netherlands, France, Russia, Belarus): Key producers of potassium chloride (Uralkali, Belaruskali), calcium chloride (Solvay), sodium acetate (BASF), sodium chloride (AkzoNobel, K+S, Salins Group), and magnesium chloride (Lanxess). European manufacturers often focus on high-purity grades.
Asia (China, India, South Korea, Japan): Significant and growing production capacity for all electrolyte salts. China is a major global supplier, particularly for calcium chloride (Weifang Ocean Chemical) and sodium acetate (Shanxi Huachang). India (Tata Chemicals) and South Korea (DL Chemical) also contribute, while Japan (TCI) is a key player in specialty and high-purity grades.

What are the key regulatory requirements for pharmaceutical-grade salts?

Compliance with pharmacopoeial monographs and GMP is paramount.

Pharmacopoeial Compliance: Salts must meet the specifications outlined in the United States Pharmacopeia (USP), European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP), or other relevant national pharmacopoeias. These monographs define identity, purity, assay limits, and impurity profiles.
- USP Specifications: For example, USP Calcium Chloride sets limits for arsenic, heavy metals, magnesium and ammonium salts, and sulfate. USP Potassium Chloride specifies limits for heavy metals, sodium, and chloride.
Good Manufacturing Practices (GMP): Manufacturers must adhere to GMP guidelines (e.g., FDA 21 CFR Part 210/211, EudraLex Volume 4) covering facility design, quality control, personnel training, process validation, documentation, and traceability.
Drug Master Files (DMFs): Manufacturers often file DMFs with regulatory agencies (e.g., FDA) to provide confidential, detailed information about their manufacturing processes, facilities, and quality controls. Pharmaceutical companies can then reference these DMFs in their drug applications.
Impurity Profiling: Strict control over impurities, including heavy metals, organic volatile impurities, and process-related byproducts, is critical. Regulatory bodies set stringent limits for these. For instance, the USP monograph for Sodium Chloride has a general impurity limit for heavy metals.
Traceability: Comprehensive batch records and robust traceability systems are required to track raw materials, production processes, and finished products from origin to distribution.

What are the current market trends and challenges impacting the supply chain?

Several factors are currently influencing the availability, pricing, and supply chain dynamics of pharmaceutical-grade electrolyte salts.

Market Trends:

Growing Demand for Intravenous Therapies: Increased prevalence of chronic diseases, aging populations, and advancements in critical care are driving demand for intravenous fluids and parenteral nutrition, directly boosting consumption of these salts.
Focus on High-Purity and Specialty Grades: Pharmaceutical companies are increasingly demanding salts with exceptionally low impurity profiles to meet evolving regulatory expectations and ensure drug safety and efficacy. This trend favors manufacturers with advanced purification technologies.
Geopolitical and Supply Chain Resilience: Recent global events have highlighted vulnerabilities in extended supply chains. Pharmaceutical companies are seeking to diversify their supplier base and secure local or regional sources for critical raw materials, leading to a demand for dual-sourcing strategies.
Sustainability and Environmental Regulations: Increasing scrutiny on chemical manufacturing processes and their environmental impact is prompting manufacturers to adopt greener production methods and invest in waste reduction. This can influence production costs and, consequently, pricing.
Consolidation within the Chemical Industry: Mergers and acquisitions among chemical producers can lead to shifts in market dominance and supply capacities, potentially affecting pricing and contract negotiations.

Market Challenges:

Raw Material Volatility: Prices and availability of key raw materials, such as industrial salt, potash, and acetic acid precursors, can fluctuate significantly due to energy costs, geopolitical factors, and agricultural demand (for potash).
Logistical Disruptions: Global shipping constraints, port congestion, and increased freight costs continue to impact the timely delivery of raw materials and finished products. This can lead to increased lead times and higher landed costs.
Regulatory Burden and Compliance Costs: Meeting and maintaining stringent pharmaceutical-grade quality standards and regulatory requirements (GMP, pharmacopoeial updates) incurs substantial costs for manufacturers, which are often passed on to the end-users.
Lead Times and Capacity Constraints: For specialized pharmaceutical-grade salts, production runs can be lengthy and infrequent, leading to extended lead times. Sudden surges in demand can strain existing manufacturing capacities, especially for smaller, specialized producers.
Competition from Emerging Markets: While beneficial for cost, an over-reliance on suppliers from regions with less stringent regulatory oversight or less robust quality systems can pose risks for pharmaceutical companies if not managed through rigorous supplier qualification.

What are the future outlook and potential supply chain risks?

The outlook for pharmaceutical-grade electrolyte salts remains positive, driven by consistent demand from the healthcare sector. However, specific risks require diligent management.

Increasing Importance of Backward Integration: Manufacturers who control their raw material sources or have strong partnerships with primary extractors are better positioned to mitigate supply volatility and cost fluctuations.
Technological Advancements in Purification: Innovations in crystallization, filtration, and ion-exchange technologies will be crucial for manufacturers to meet increasingly stringent purity requirements and differentiate themselves.
Digitalization of Supply Chains: Greater adoption of digital tools for inventory management, demand forecasting, and real-time tracking will enhance supply chain visibility and responsiveness.
Geopolitical Instability: Ongoing geopolitical tensions can disrupt trade routes, impact energy prices affecting production costs, and lead to export/import restrictions. For instance, sanctions on major potash producers have historically caused price spikes and supply concerns.
Climate Change Impacts: Extreme weather events can affect the availability of certain raw materials (e.g., solar salt production) and disrupt transportation networks, posing indirect risks to the supply chain.

Key Takeaways

The supply of pharmaceutical-grade calcium chloride, magnesium chloride, potassium chloride, sodium acetate, and sodium chloride is concentrated among a mix of large multinational chemical corporations and specialized producers adhering to strict GMP and pharmacopoeial standards.
North America, Europe, and Asia are the primary manufacturing hubs, with China emerging as a significant global supplier, particularly for non-potash-derived salts.
Regulatory compliance, including USP/EP monograph adherence and GMP, is a critical differentiator and a significant cost factor for manufacturers.
Current market trends indicate sustained demand driven by the growth of intravenous therapies and an increasing focus on high-purity grades.
Supply chain challenges include raw material price volatility, logistical disruptions, and the ongoing burden of regulatory compliance.
Future risks are primarily linked to geopolitical instability and the need for enhanced supply chain resilience through backward integration and technological advancements in purification.

Frequently Asked Questions

What is the primary difference between industrial-grade and pharmaceutical-grade sodium chloride? Pharmaceutical-grade sodium chloride (e.g., USP Purified Salt) undergoes significantly more rigorous purification processes to remove impurities like heavy metals, organic compounds, and other salts to meet stringent pharmacopoeial standards (USP, EP, JP). Industrial-grade salt may contain higher levels of impurities and is not suitable for direct human administration or use in drug formulations.
How do manufacturers ensure the pharmaceutical grade of potassium chloride derived from mining? Potassium chloride mined from natural deposits is subjected to extensive purification steps. These include dissolution, filtration, crystallization, and drying processes to remove contaminants such as sodium chloride, sulfates, magnesium, and calcium. The final product must then pass strict analytical testing against USP/EP monographs before it can be certified as pharmaceutical grade.
Are there any significant differences in the manufacturing processes for sodium acetate and sodium chloride that impact their supply? Sodium chloride is primarily sourced through mining (rock salt) or evaporation of brine (sea salt, lake salt). Sodium acetate is synthesized, typically through the reaction of acetic acid with sodium bicarbonate or sodium hydroxide. This difference in origin means their supply chains are influenced by different factors – NaCl by geological deposits and evaporation conditions, and sodium acetate by the availability and cost of acetic acid and sodium bases.
What are the key indicators of potential supply chain disruptions for magnesium chloride? Key indicators include significant increases in the cost of raw materials like magnesium hydroxide or magnesium carbonate, energy price spikes (as production is energy-intensive), geopolitical instability impacting key producing regions (e.g., areas with significant brine reserves), and global shipping delays affecting the transport of bulk chemicals.
How does the shelf life of pharmaceutical-grade electrolyte salts compare, and does it impact inventory management? Pharmaceutical-grade electrolyte salts, when stored under appropriate conditions (typically dry, cool, and protected from light), generally have very long shelf lives, often exceeding several years. This is due to their stable chemical nature. This stability simplifies inventory management for pharmaceutical companies, allowing for larger stockholding without significant spoilage risk, although expiration dating is still meticulously managed.

Citations

[1] United States Pharmacopeia. (Current Edition). The United States Pharmacopeia and The National Formulary.

[2] European Directorate for the Quality of Medicines & HealthCare. (Current Edition). European Pharmacopoeia.

[3] Food and Drug Administration. (2023). Current Good Manufacturing Practice (CGMP) in Manufacturing, Processing, Packing, or Holding of Drugs; General. 21 CFR Part 210 & 211.

[4] Solvay S.A. Corporate Website. (Accessed October 2023). Product Information.

[5] Cargill, Inc. Corporate Website. (Accessed October 2023). Product Information.

[6] OCI Wyoming, LP. Corporate Website. (Accessed October 2023). Product Information.

[7] U.S. Magnesium, LLC. Corporate Website. (Accessed October 2023). Product Information.

[8] Uralkali PJSC. Corporate Website. (Accessed October 2023). Product Information.

[9] Nutrien Ltd. Corporate Website. (Accessed October 2023). Product Information.

[10] Eastman Chemical Company. Corporate Website. (Accessed October 2023). Product Information.

[11] Avantor, Inc. (J.T. Baker). Corporate Website. (Accessed October 2023). Product Information.

[12] AkzoNobel N.V. Corporate Website. (Accessed October 2023). Product Information.

Suppliers and packagers for generic pharmaceutical drug: CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE